Managing the unmet need around inactive progression in MS

About Us CRU Directors CRU Investigators Leading Trial Site Clinical Trials ALS Brain Tumour Dementia Epilepsy Intensive Care Unit Movement Disorders Multiple Sclerosis Neuromuscular Stroke ASHG SYMPOSIUM Program Abstracts Registration Sponsors Sponsorship Form...

RNA therapy could offer a new approach to treat Charcot-Marie-Tooth

About Us CRU Directors CRU Investigators Leading Trial Site Trials Recruiting ALS Brain Tumour Dementia Epilepsy Intensive Care Unit Movement Disorders Multiple Sclerosis Neuromuscular Stroke Patients Advanced Therapies ASHG SYMPOSIUM Registration Program Abstracts...

A new genetic target for Alzheimer’s treatments

About Us CRU Directors CRU Investigators Leading Trial Site Trials Recruiting ALS Autism Brain Tumour Dementia Epilepsy Intensive Care Unit Migraine Movement Disorders Multiple Sclerosis Neuromuscular Neuro-Surgery Stroke Patients Advanced Therapies ASHG SYMPOSIUM...

Powered by
►
Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.
None
►
Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.
None
►
Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.
None
►
Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.
None
Powered by